Cell locations for AQP1, AQP4 and 9 in the non-human primate brain. by Arciénega, I.I. et al.
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dELL LOCATIONS FOR AQP1, AQP4 AND 9 IN THE NON-HUMAN
RIMATE BRAIN
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bstract—The presence of three water channels (aquaporins,
QP), AQP1, AQP4 and AQP9 were observed in normal brain
nd several rodent models of brain pathologies. Little is
nown about AQP distribution in the primate brain and its
nowledge will be useful for future testing of drugs aimed at
reventing brain edema formation. We studied the expres-
ion and cellular distribution of AQP1, 4 and 9 in the non-
uman primate brain. The distribution of AQP4 in the non-
uman primate brain was observed in perivascular astro-
ytes, comparable to the observation made in the rodent
rain. In contrast with rodent, primate AQP1 is expressed in
he processes and perivascular endfeet of a subtype of as-
rocytes mainly located in the white matter and the glia limi-
ans, possibly involved in water homeostasis. AQP1 was also
bserved in neurons innervating the pial blood vessels, sug-
esting a possible role in cerebral blood flow regulation. As
escribed in rodent, AQP9 mRNA and protein were detected
n astrocytes and in catecholaminergic neurons. However
dditional locations were observed for AQP9 in populations
f neurons located in several cortical areas of primate brains.
his report describes a detailed study of AQP1, 4 and 9
istributions in the non-human primate brain, which adds to
he data already published in rodent brains. This relevant
pecies differences have to be considered carefully to assess
otential drugs acting on AQPs non-human primate models
efore entering human clinical trials. © 2010 IBRO. Published
y Elsevier Ltd. All rights reserved.
ey words: aquaporins, astrocyte, water homeostasis, brain
dema, energy metabolism.
quaporins (AQPs) are a family of water channel pro-
eins ubiquitously distributed in the living world (Amiry-
oghaddam and Ottersen, 2003). To date, eight aqua-
orins are found to be expressed in the rodent brain: AQP1,
QP3, AQP4, AQP5, AQP6, AQP8, AQP9 and AQP11, but
nly AQP1, AQP4 and AQP9 have been clearly identified in
rain cells in vivo (Badaut et al., 2007).
Correspondence to: J. Badaut, Department of Pediatrics, Loma Linda
niversity School of Medicine, Loma Linda, CA 92350, USA. Tel:
1-909-558-8242; fax: 1-909-558-0479.
-mail address: jbadaut@llu.edu (J. Badaut).c
bbreviations: AQPs, aquaporins; GFAP, glial fibrillary acidic protein;
MO, neuromyelitis optica; SCI, spinal cord injury.
306-4522/10 $ - see front matter © 2010 IBRO. Published by Elsevier Ltd. All right
oi:10.1016/j.neuroscience.2010.02.059
1103AQP4 was the first AQP reported in rat brain (Jung et
l., 1994) and was shown to be highly expressed in
erivascular astrocytic endfeet (Nielsen et al., 1997). Its
resence in rodent brain was observed around all blood
essels of any size, in white and gray matter and in all
rain structures (Badaut et al., 2000a). It is the dominant
ater channel localized in astrocyte foot processes, in
ontact with blood vessels and the cerebrospinal fluid-
rain interface (pial and ependymal surfaces) (Badaut et
l., 2002). Since 1997, AQP4 is the most studied AQP in
ammalian brains and implicated in the physiopathology
f brain edema, with a dual function depending on the
athological model used (Badaut et al., 2007; Tait et al.,
008). In mouse models of cytotoxic edema (water intox-
cation and stroke), AQP4 deletion has been shown to be
rotective by reducing edema formation and improving
urvival (Manley et al., 2000). It was therefore proposed to
lay a central role in the formation of cytotoxic brain
dema. In vasogenic edema, AQP4 plays the opposite role
here its deletion results in decreased edema clearance
nd further progression of disease (Papadopoulos et al.,
004). There is now more evidence that AQP4 is involved
n human CNS pathologies. Indeed, recent reports dem-
nstrate the presence of IgG recognizing AQP4 in the
erum of patients suffering from neuromyelitis optica
NMO), an autoimmune demyelinating disease affecting
ptic nerves and the spinal cord (Lennon et al., 2005). This
erum IgG autoantibody (IgG-NMO) served as a specific
arker and was found to bind selectively to the extracel-
ular face of the AQP4 water channel (Lennon et al., 2005).
urthermore, increased AQP4 expression was also ob-
erved in reactive astrocytes during glial scar formation
nd facilitated astrocyte migration (Saadoun et al., 2005b),
s well as in other human pathologies such as astrocyto-
as and adenocarcinomas (Saadoun et al., 2002b); in
poradic Creutzfeldt–Jakob disease (sCJD) (Iwasaki et al.,
007; Rodriguez et al., 2006) and in HIV-related dementia
St Hillaire et al., 2005). On the other hand, decreased
QP4 expression was found in the cerebellum of subjects
ith autism (Fatemi et al., 2008a) and in animal models of
utism, where prenatal influenza infection in mice resulted
n a down regulation of AQP4 expression (Fatemi et al.,
008b, 2005).
AQP1 was first described in the choroid plexus of
odent and primate brains and thought to be involved in the
roduction of cerebrospinal fluid (Oshio et al., 2005).
QP1 is also expressed throughout the body of mamma-
ians in many endothelial cells (Nielsen et al., 1993), but its
xpression is suppressed in the specialized endothelial
ells of the blood–brain barrier (Dolman et al., 2005).
s reserved.
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I. I. Arciénega et al. / Neuroscience 167 (2010) 1103–11141104ndeed, the presence of astrocytes inhibits the expression
f AQP1 in endothelial cells (Dolman et al., 2005). Re-
ently, the dorsal horn of the spinal cord and the trigeminal
ensory ganglia were identified as new cellular locations
or AQP1 (Nandasena et al., 2007; Oshio et al., 2006). In
hese areas, AQP1 may play a role in pain sensation as,
nterestingly, the expression of AQP1 in small diameter
ensory fibers of the dorsal horn is locally significantly
ncreased 10 days after spinal cord injury (SCI), persisting
p to 11 months post-contusion. AQP1 is proposed to play
wo distinctive roles in the reaction after SCI: (i) at early
ime points post-SCI increase in expression contributes to
strocytic reactivity and neuronal swelling and (ii) the de-
ayed increase in expression contributes to development of
hronic neuropathic pain after SCI (Nesic et al., 2008).
In human, AQP1 expression was also found to be
nhanced in reactive astrocytes with highly branched pro-
esses surrounding blood vessels, along the glial scar and
ccumulating in brain lesions in Alzheimer’s disease,
reutzfeldt–Jakob disease, multiple sclerosis and in isch-
mic lesions (Misawa et al., 2008; Satoh et al., 2007).
nder these pathological conditions, AQP1 is suggested to
lay a complementary role to AQP4 in brain water ho-
eostasis (Misawa et al., 2008; Satoh et al., 2007). To
ate, regional and cellular distribution of AQP1 in healthy
uman and non-human primate brain has never been in-
estigated in detail.
The aquaglyceroporin, AQP9 has been reported to be
resent in glial cells (Badaut et al., 2001; Elkjaer et al.,
000) and in catecholaminergic neurons (Badaut et al.,
004) in rodent brains. With regards to AQP9 localization
nd its permeability properties, AQP9 was hypothesized to
lay a role in brain energy homeostasis (Badaut and Regli,
004). Interestingly, the level of AQP9 expression is in-
reased in astrocytes after stroke (de Castro Ribeiro et al.,
006) and in catecholaminergic neurons in a diabetes
odel in rats (Badaut et al., 2008). Despite many publica-
ions which describe the presence of AQP9 in the rodent
rain (Amiry-Moghaddam et al., 2005; Badaut et al., 2001,
004; de Castro Ribeiro et al., 2006; Elkjaer et al., 2000;
sukaguchi et al., 1998), it has now became a matter of
ebate following a recent publication (Rojek et al., 2007),
uggesting that AQP9 is not expressed in the mouse brain
nd raising the question of its expression in primate brain.
Most investigations have been carried out in rodent
rains (mice and rats) and there is no description of AQPs
n normal primate brains. Cells in the CNS differ between
odents and primates, for example: human protoplasmic
strocytes manifest a threefold larger diameter and have
enfold more primary processes than those of rodents
Oberheim et al., 2006). Since AQP1, 4 and 9 are all found
n astrocytes (Badaut et al., 2007), it is important to inves-
igate possible evolutionary differences between rodents
nd primates, in the expression and distribution of AQPs.
his knowledge will be essential for the development of
uture therapeutic agents targeting AQPs to prevent brain
dema formation (Tait et al., 2008). Using RT-PCR and
mmunohistochemical approaches, we provide new data Xn the expression and regional, cellular distribution of
QP1, AQP4 and AQP9 in the primate brain.
EXPERIMENTAL PROCEDURES
issue preparation
he experiments were conducted on sections from three adult
onkey brains (Macaca fascicularis). The animals were between
and 8.5 years old and weight 2.9–3.5 kg. They lived in group of
our in a space of 16 m3. They were fed once a day and had free
ccess to water. Animal care was conducted in accordance with
he NIH Guide for the care and use of laboratory animals (ISBN
-309-05377-3; 1996) and was approved by the local Swiss vet-
rinary authority.
The animals were killed under deep (lethal) anaesthesia (90
g sodium pentobarbital/kg body weight, Sigma-Aldrich, St.
ouis, MO, USA) by transcardiac perfusion with 0.9% saline (400
l). The perfusion was continued with fixative (3 l of 4% phos-
hate-buffered paraformaldehyde (Sigma-Aldrich, St. Louis, MO,
SA) in 0.1 M phosphate buffer, pH 7.6) and solutions (2 l each)
f the same fixative containing increasing concentrations of su-
rose (10%, 20%, and 30%). The brain was dissected and placed
n a 30% sucrose in phosphate buffer solution for cryoprotection
or 7 days. Fifty micrometres thick sections were prepared with a
ryotome (HM560, MICROM, Volketswil, Switzerland) and were
tored at 80 °C in cryoprotection solution (50 mM phosphate
uffer pH 7.4) containing 25% glycerol (G7893, Sigma-Aldrich, St
ouis, MO, USA) and 30% ethylene glycol (33068, Ridel-de-Haën,
eelze, Germany).
issue analysis
he Macaca fascicularis brains were analyzed by steps of 1 mm
oronal sections, beginning at32 mm and pursuing until7 mm
ased on the Atlas of the primate brain published from the Wash-
ngton University (http://braininfo.rprc.washington.edu/). Most at-
ention was given to coronal sections between 5 and 13 mm.
hese sections contain cerebral structures that have previously
een studied in rodents and where thus useful to serve as com-
arison in our studies. Cerebellum was not included in our studies.
eal Time Nested-PCR experiments
RNA was extracted from fixed brain slices from the three Ma-
aca fascicularis monkeys adjacent to slices of interest used for
mmunohistochemistry using RNeasy® FFPE extraction kit (Qia-
en, Hilden, Germany) and following the procedure proposed by
he company. The quality of the mRNA was assessed using a
ioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA).
DNAs were generated from 500 ng of total mRNA using Biolabs
-MuLV Reverse Transcriptase (200 U/l) as described by the
upplier. PCR experiments were performed using the HotStarTaq
aster Mix Kit from Qiagen using 2 l of cDNA/5 pmol of primer
nd 35 cycles using a Thermocycler (Biometra, Goettingen Ger-
any) with denaturation (94 °C, 30 s), annealing (48 °C, 45 s for
QP1, 4 and 9 and 56 °C, 45 s for Actin) and extension (72 °C,
0 s). The Nested-PCR reaction (not used for Actin amplification)
sed 1 l of the first PCR product with 5 pmol of primer and
onsisted of 30 cycles in the same conditions as for the first PCR
eactions. Primers used were specific for human AQP1, human
QP4, human AQP9 and human Actin and are specified in Table
. Specificity of PCR products were controlled by sequence anal-
sis (data not shown).
ingle immunolabeling for regional studies
mmunolabeling was carried out in PBS containing 0.3% Triton
-100 and 0.25% bovine serum albumin on adjacent serial 50-
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I. I. Arciénega et al. / Neuroscience 167 (2010) 1103–1114 1105m-thick coronal free floating sections of Macaca fascicularis
rain. After each incubation, sections were rinsed in PBS 310
in. The sections were first incubated overnight at 4 °C with
otation with anti-AQP1 (dilution: 1/200; Chemicon, Temecula,
A, USA), anti-AQP4 (dilution: 1/200; Chemicon, Temecula, CA,
SA) and anti-AQP9 (dilution: 1/200; Alpha Diagnostics, San
ntonio, TX, USA). After washing, floating sections were then
ncubated for 2 h at room temperature with a biotinylated second-
ry goat anti-rabbit antibody (dilution: 1/200; Vector Laboratories,
urlingame, CA, USA). The sections were then rinsed and ex-
osed for 1 h to avidin-biotin complex solution (Vectastain kit;
ector Laboratories, Burlingame, CA, USA) before application of
iaminobenzidine (DAB; Vector kit, Vector Laboratories). Floating
ections were rinsed, mounted on slides and then coverslipped
ith Eukit Medium. Controls were performed by omitting primary
ntibody. Control sections showed no detectable labeling.
ouble immunofluorescence
ections were incubated with either one primary antibody (see
able 2) or a mixture of two primary antibodies over night at 4 °C
ith rotation and then with either one secondary antibody or a
ixture of two secondary antibodies: anti-rabbit coupled to Alexa-
ye 594 nm (dilution: 1/1000, Invitrogen, Switzerland) and anti-
ouse coupled to Alexa-dye 488 nm (dilution: 1/1000, Invitrogen,
witzerland) for 2 h at room temperature. After immunofluores-
ence, sections were mounted and coverslipped with mounting
edium Vectashield (Vector Laboratories, Burlingame, CA, USA).
ontrols were performed by omitting either one or both primary
ntibodies. Control sections showed no detectable labeling.
able 1. Gene-specific N-PCR primers and their respective fragment
enBank accession Primer Nucleotide seq
41517 Human AQP1 Fo1 5=-GTC CAG G
Human AQP1 Re1 5=-CCC TCC A
Human AQP1 Fo2 5=-ACC GCG T
Human AQP1 Re2 5=-ACT AGC A
63412 Human AQP4 Fo1 5=-TTG CTT TG
Human AQP4 Re1 5=-CTG TTG TC
Human AQP4 Fo2 5=-CTG TCT TC
Human AQP4 Re2 5=-GGG ATT C
B008775 Human AQP9 Fo1 5=-GCC CAA G
Human AQP9 Re1 5=-GCA GAC A
Human AQP9 Fo2 5=-GTC CTT TG
Human AQP9 Re2 5=-GGC CCA C
Fo, forward; Re, reverse.
able 2. Antibodies and dilutions used in this study
rimary antisera Secondary antisera
nti-AQP1 (Chemicon, rabbit,
1/200)
Alexa 594 goat anti-rabbit
(Invitrogen, 1/1000)
nti-AQP4 (Chemicon, rabbit,
1/200)
Alexa 488 goat anti-mouse
(Invitrogen, 1/1000)
nti-AQP9 (Alpha Diagnostics,
rabbit, 1/200)
CY3 goat anti-rabbit (Sigma,
1/1000)
nti-GFAP (Sigma, mouse, 1/500) Alexa 488 goat anti-mouse
(Invitrogen, 1/1000)
nti-TH (Chemicon, mouse, 1/20) FITC goat anti-mouse (Sigma,
1/1000)
nti-NF 70200 kDa (Bio-Science Alexa 488 goat anti-mouse
Products, mouse, 1/100) (Invitrogen, 1/1000) m
Amage acquisitions
he entire section of a single immunostaining was scanned by a
P Scanjet 4850 with a resolution of 600 pixels/inch to obtain a
ingle picture of the whole section.
Single immunolabeling revealed by DAB staining was observed
nd photographed using optical microscopy (Olympus BX40, Swit-
erland). Immunofluorescent preparations were examined using epi-
uorescence microscopy (Olympus BX 40, Switzerland), equipped
ith a Qimagin, QICAM Fast (1394) camera and ExploraNova Fluo
D software (ExploraNova, La Rochelle, France). The epifluores-
ence of FITC, CY3, Alexa 488 and Alexa 594 was successively
hotographed through different filters and then superposed.
RT-PCR images were acquired with an infrared Scanner (Od-
ssey, from Licor, Germany) detecting Syto60 and using software
dyssey 1.2.
RESULTS
etection of AQP4, 1 and 9 mRNAs in Macaca
ascicularis brain
he expression of AQP4, 1 and 9 mRNAs was first eval-
ated by RT-PCR using fixed Macaca fascicularis brain
lices, adjacent to the slices used for immunohistochemi-
al studies. Fragments of the expected size were obtained
or AQP4, 1 and 9 cDNAs respectively 298, 372 and 364
p from all the three Macaca fascicularis brains (Fig. 1).
arge amounts of AQP1 and 4 cDNA were detected,
Position Final fragment size
GTG AAG GT-3= 169–189 372 bp
CCT CCT GG-3= 1306–1325
TGT GGA CC-3= 752–772
GTC CCT TT-3= 1104–1124
CAG CAT TG-3= 245–264 298 bp
ACC TCC AT-3= 852–871
CG CAG CCC AG-3= 364–386
GGC ACC AG-3= 643–662
CTC AGT CG-3= 349–369 364 bp
GGG TGG AT-3= 1197–1216
TGG AAA ACT GC-3= 603–625
GAA TCC ACC-3= 947–967
ig. 1. Real time PCR analysis of fixed Macaca fascicularis brain
issue. Fragments of expected sizes for AQP4, 1 and 9 respectively
98, 372 and 364 bp were obtained. A large amount of AQP1 and 4size
uence
AC AAC
CT GCA
GA AGG
GG TGG
G ACT
C TCC
T ACA T
AT GCT
CT ATT
AA ACT
C TGG
TA CAGRNA is detected, whereas we observe a weak, but specific signal for
QP9 mRNA.
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I. I. Arciénega et al. / Neuroscience 167 (2010) 1103–11141106hereas a weak, but specific signal was obtained for
QP9 cDNA (Fig. 1) demonstrating the presence of AQP9
RNA in Macaca fascicularis brain on adjacent slices
sed for immunolabeling (see below).
QP4 immunolabeling in astrocytic perivascular
ndfeet
QP4 labeling was systematically studied in all structures
f the fixed Macaca fascicularis brain. Low magnification
Fig. 2A) showed that AQP4 staining was present in grey
atter (GM), in several brain areas such as the anterior
halamic nuclear group (ATh), the ventral (VTh) and medial
MeTh) thalamic nuclear group, the substantia nigra (SN),
he putamen (Pu), the globus pallidus (GP), the tail (TCd)
nd body (BCd) of the caudate nucleus and the granule
ell layer of the dentate gyrus (DG). High AQP4 staining
as also observed in the glia limitans, pia mater and the
ig. 2. AQP4-immunoreactivity in a Macaca fascicularis coronal se
bserved in grey matter (asterix), in the anterior thalamic nuclear grou
ubstantia nigra (SN), in the putamen (Pu), in the interthalamic adhes
audate nucleus, in the granule cell layer of the dentate gyrus (DG), in t
f fornix (pcfx). 3V, third ventricle; Ath, anterior thalamic nuclear group
erebral crus; Cl, claustrum; DLG, dorsal nucleus of lateral geniculat
nsula; itha, interthalamic adhesion; LH, lateral hypothalamic area; MN
t, reticular thalamic nuclei; st, stria terminalis; Sub, subiculum; eml,
indicated by open boxes A, B, C) and comparison of AQP4 immunola
olarizes to the astrocytic perivascular endfeet (arrows). (C) In white
arrows). Fewer vessels are present in white matter compared to g
QP4-immunoreactivity (IR) in the granule cell layer (GL) of the dentat
erivascular astrocytic endfeet (arrows). PL, polymorphic layer; GL, gr
m in (B, C, D).osterior column of fornix (pcfx). The wide distribution of oQP4 staining is in accordance with the intense band
bserved in RT-PCR experiments (Fig. 1).
Higher magnification of grey and white matter (Fig. 2B,
) revealed, as in rodents, that AQP4 staining is polarized
n the astrocytic perivascular endfeet along blood vessels.
higher vascular density in the grey matter compared to the
hite matter might explain why AQP4-immunoreactivity
AQP4-IR) was stronger in the grey matter (Fig. 2A). In the
entate gyrus of the hippocampus, AQP4 staining was ob-
erved in astrocyte processes in contact with blood vessels
nd also in astrocyte processes localized in between neuro-
al cell bodies (Fig. 2D). AQP4 expression and distribution
re comparable between rodent and primate brains, suggest-
ng a conserved functional role in evolution.
QP1 distribution in Macaca fascicularis brain
QP1 labeling was systematically studied in all structures
nterior commissure (AC) 5 mm. (A) Immunolabeling of AQP4 is
in the ventral (VTh) and medial (MeTh) thalamic nuclear group, in the
, in the globus pallidus (GP), in the tail (TCd) and body (BCd) of the
itans, in the pia mater (single lined arrow) and in the posterior column
dy of lateral ventricle; CA1, CA2 and CA3, Cornu Ammonis fields; ccr,
c, external capsule; exc, extreme capsule; ic, internal capsule; Ins,
illary nuclei; opt, optic tract; PPHG, posterior parahippocampal gyrus;
medullary lamina. Higher magnification of several zones of Fig. 2A
grey (GM) and white matter (WM). (B) In grey matter, AQP4 staining
AQP4 staining also polarizes to the astrocytic perivascular endfeet
r. (D) Higher magnification of the indicated zone in Fig. 2A shows
the hippocampus. AQP4 staining in the granule cell layer labels also
l layer; ML, molecular cell layer; vx, vessels. Bar1 cm in (A); bar25ction at a
p (ATh),
ion (itha)
he glia lim
; BLV, bo
e body; e
, mamm
external
beling in
matter,
rey matte
e gyrus inf fixed Macaca fascicularis brain. In accordance with pre-
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I. I. Arciénega et al. / Neuroscience 167 (2010) 1103–1114 1107ious studies performed in rodent brains (de Castro Ri-
eiro et al., 2006; Gomori et al., 2006), immunolabeling
ith anti-AQP1 antibodies was observed in the choroid
lexus epithelial cells (Fig. 3), showing that the commercial
PQ1 antibody specifically recognized the AQP1 epitope
n primate brains.
AQP1 immunolabeling (Fig. 4A) was not only restricted
o the choroid plexus, but was also detected in white matter
racts, including the subcortical white matter, the internal
ic), external (ec) and extreme (exc) capsule and in the
erebral crus (ccr) (Fig. 4A). AQP1 staining was also ob-
erved around the optic tract (opt), in the tail (TCd) and
ody (BCd) of the caudate nucleus, in the lateral medullary
amina which separates the putamen (Pu) from the globus
allidus (GP), in the hippocampus Cornu Ammonis fields
A1 to CA3 and in the granule cell layer of DG (Fig. 4A).
t is interesting to note that AQP1 immunoreactivity does
ot overlap with AQP4 staining (Figs. 2A and 4A) in sev-
ral regions (white and grey matter, medial (MeTh) and
entral (VTh) thalamic nuclear group, substantia nigra
SN), putamen (Pu), cerebral crus (ccr)).
Observations at higher magnification of the outlined
egions shown in Fig. 4A revealed that AQP1-IR in grey
nd white matter was both due to an astrocyte-like label-
ng, with staining on cellular processes and perivascular
ndfeet (Fig. 4B, C). Higher magnification of the hippocam-
us (Fig. 4D) revealed a strong AQP1-immunolabeled
ranule cell layer of the DG with immunolabeled cell bod-
es and processes reaching from the granule cell layer into
he molecular layer of the DG.
Double immunofluorescence with anti-glial fibrillary
cidic protein (GFAP) and anti-AQP1 antibodies showed
o-localization of these markers in the perivascular astro-
ytes suggesting that AQP1 is expressed in astrocytes
Fig. 5A–C). Astrocytic AQP1 immunoreactivity could also
e seen in the glia limitans (Fig. 5A–C). In the white matter
ig. 3. Double immunohistochemistry with anti-GFAP (green, ar-
ows), anti-AQP1 (red, arrowheads) antibodies and DAPI nucleus
taining (blue). This experiment reveals the specificity of the anti-
QP1 antibody for epithelial cells of choroid plexus in accordance with
revious publications. Bar25 m. For interpretation of the references
o color in this figure legend, the reader is referred to the Web version
f this article.Fig. 4C), we also note immunoreactivity in stellate cell aodies, suggesting expression in astrocytes. These la-
eled astrocytic soma contribute to the strong labeling in
hite matter (Fig. 4A, C). Comparison of GFAP and AQP1
taining in Fig. 5A shows that not all GFAP positive cells
ere labeled AQP1. This result is in contrast to AQP4-IR
hich is observed in all GFAP stained astrocytes (data not
hown). Here, we provide evidence that AQP1 may be a
arker of a distinctive subpopulation of astrocytes present
n the white matter of the primate brain.
Higher magnification of the emerging oculomotor nerve
Fig. 5D, E) revealed GFAP-AQP1-IR between the nerve
bers; a space filled by Schwann cells and endoneurium.
oth nerve fibers and Schwann cells are enveloped by
ndoneurium, a loose connective tissue rich in vasa ner-
orum. Previous studies showed GFAP-labeling around
erve fibers in Schwann cells (Jessen and Mirsky, 1984;
essen et al., 1990). Thus, AQP1 and GFAP co-localiza-
ion in Schwann cells (Fig. 5D, E) could indicate a role in
xon to Schwann cell signaling (Jessen et al., 1990), im-
ortant for the maintenance of the nerve fiber microenvi-
onment and its physiological functioning.
Interestingly, AQP1 staining without GFAP labeling
as present on pial blood vessels (Fig. 5D, F). We noted
QP1-IR depicting soma as well as prolongations (Fig.
F). Double immunolabeling with anti-Neurofilament (NF)
ntibodies clearly showed that AQP1 labeling is located in
euronal soma (Fig. 6) and their bipolar processes running
round the blood vessels (Figs. 5F and 6). AQP1 labeling
n these processes surrounded the NF staining, suggesting
hat AQP1 was inserted in the cell membrane of these
eurons which innervate the pial blood vessels (Fig. 6).
QP9 immunolabeling in catecholaminergic neurons,
n cortical isolated neurons and in astrocytes
QP9 immunolabeling was systematically studied in all
tructures of fixed Macaca fascicularis brain. Regional ob-
ervations (Fig. 7A) revealed AQP9 immunoreactivity pre-
ominantly in the grey matter, the medial (MeTh) and
entral (VTh) thalamic nuclear group, the lateral geniculate
ody (DLG), the substantia nigra (SN), the tail (TCd) and
ody (BCd) of the caudate nucleus, the Cornu Ammonis
elds CA1 to CA3, the granule cell layer of the DG and the
ubiculum (Sub) of the hippocampus.
In the insula cortex (Fig. 7B), the precentral gyrus (Fig.
C) and other brain areas, AQP9 staining was located in
he astrocytic cell bodies and processes running towards
essels and in their perivascular endfeet. This AQP9 lo-
alization is in agreement with previous publications in
odent brains (Badaut et al., 2001, 2004), and double
mmunolabeling with GFAP shows co-localization of both
arkers (data not shown).
AQP9 immunoreactivity was also observed in several
eurons (Figs. 7D and 8), indicating TH-positive neurons
ocated in the substantia nigra (Fig. 8), in agreement with
bservations in rodent brains (Badaut et al., 2004; de
astro Ribeiro et al., 2006) where AQP9 expression was
een in catecholaminergic neurons. In these neurons,
QP9 labeling was observed in the cell membrane as well
s in the cytoplasm (Fig. 8). In primates, additional AQP9
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ell as in other brain areas such as the fourth layer of the
recentral gyrus (primary motor cortex) (Fig. 7D). AQP9-
abeled neurons exhibiting an oval shape were found lo-
ated in the cortical layer IV (Fig. 7D). Interestingly,
QP9-IR was observed in the DG (Fig. 7A, E, F). Higher
agnification revealed a strongly immunolabeled granule
ell layer of the DG, with immunolabeled cell bodies and
rocesses reaching from the granule cell layer into the
olecular layer (Fig. 7E, F). Cell bodies were stained with
QP9 in the granular layer as well as in the polymorphic
ig. 4. AQP1-immunoreactivity in a Macaca fascicularis coronal se
ined arrow), in white matter (asterix) such as in the extreme (exc),
nterior part of the cerebral peduncle containing corticospinal, cortic
tria terminalis (st.), as well as in the lateral medullary lamina (arro
n the external medullary lamina (eml), separating the ventral tha
tructures like the glia limitans (pentagonal arrows), and pia mater
ctivity is also revealed around the tail (TCd) and body (BCd) of
eparating the ventral thalamic nuclear group (VTh) from the subs
ranular and molecular cell layers of the dentate gyrus (DG) of the hi
pcfx). 3V, third ventricle; ATh, anterior thalamic nuclear group; B
eniculate body; Ins, Insula; MeTh, medial thalamic nuclear grou
ubiculum. (B) A higher magnification of the grey matter (GM) reve
arrows) as well as their immunolabeled prolongations (arrow heads
QP1 staining is stronger in white matter (WM) than in grey matter (
mmunoreactivity in stellate cell bodies (double lined arrows), sugg
mmunolabeled perivascular endfeet (single lined arrows) and imm
ippocampus of Macaca fascicularis brain. The hippocampus re
agnification allows identification of immunolabeled cell bodies
mmunolabeled processes (closed arrow heads) reaching from granu
he staining in perivascular end feet, suggesting the presence of a
ayer. Bar1 cm in (A); bar25 m in (B–D).ayer (Fig. 7F). 2DISCUSSION
nterest in AQP expression in human pathologies is ori-
nted towards the development of new drugs to prevent
dema formation. Recently, the relevance to study AQP4
n human diseases has been strengthened by the discov-
ry of the AQP4 antibody in blood of patient suffering of
euromyelitis optica (NMO), and is now a biomarker of this
eurodegenerative disease (Lennon et al., 2005; Weinsh-
nker et al., 2006). However, most AQP studies have
een carried out in the rodent brain (Badaut et al., 2007,
5 mm. (A) Immunolabeling is found in the choroid plexus (double
(ec) and internal capsule (ic), in the cerebral crus (ccr) which is the
and corticobulbar motor tracts, around the optic tract (opt) and the
), separating the putamen (Pu) from the globus pallidus (GP) and
clear group (VTh) from the thalamic reticular nucleus (Rt). Other
ined arrows) surrounding the glia limitans, are labeled. Immunore-
date nucleus, in the interthalamic adhesion (itha), in the field H,
ra (SN), in Cornu Ammonis fields CA1, CA2 and CA3 and in the
us. Immunoreactivity is also strong in the posterior column of fornix
of lateral ventricle; Cl, claustrum; DLG, dorsal nucleus of lateral
ammillary nuclei; PPHG, posterior parahippocampal gyrus; Sub,
vessels (vx) surrounded by immunolabeled perivascular endfeet
ting the presence of astrocytes. (C) As seen in the coronal section,
ontrast to grey matter (GM), in white matter (WM) we also observe
QP1 expression in astrocytic cell bodies. These cell bodies show
ed prolongations (arrow heads). (D) AQP1-immunoreactivity in the
eals a strongly immunolabeled granule cell layer (GL). Higher
rrow heads) in the granule cell layer of the dentate gyrus and
yer to the molecular layer (ML) of the DG. Single lined arrows show
. PL, polymorphic layer; GL, granule cell layer; ML, molecular cellction at 
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rain tissue samples, showing regulation of AQP ex-
ig. 5. (A–C) AQP1 (red)-GFAP (green) double immunofluorescence in the
ingle lined arrows point out an astrocyte with its double immunolabeled prolo
egative (double lined arrows in Fig. 5A–C). (D) AQP1 staining in red, GFAP
mmunoreactivities in the cerebral crus, a strongly GFAP stained oculomo
tructures (double lined arrows). (E) Higher magnification, of the zone indica
ositive Schwann cells (hexagonal-arrows) in the endoneurial space around
ater surrounding the emerging oculomotor nerve, reveals AQP1 immunola
tained fibers, suggesting a neuronal formation which runs along a blood ve
ar0.25 mm. For interpretation of the references to color in this figure lege
ig. 6. AQP1-labeling (red) and neurofilament (NF, green) staining are
olocalized on a pial vessel. Neuronal cell bodies on the pial vessel
re AQP1-immunolabeled (arrow heads) and their NF-positive ax-
ns are surrounded by AQP1 immunolabeling (double lined arrows).a
ar25 m. For interpretation of the references to color in this figure
egend, the reader is referred to the Web version of this article.ression in pathological conditions. Human brain tissues
ere obtained after surgery (Badaut et al., 2003; Fatemi
t al., 2008a; Saadoun et al., 2002a,b; Satoh et al.,
007; Suzuki et al., 2006) or autopsy (Satoh et al.,
007). To date, little is known about the distribution and
xpression of AQPs in normal primate brains. Here we
eport for the first time, the expression and cell localiza-
ion of the three most studied AQPs in the rodent brain,
QP1, 4 and 9, in the Macaca fascicularis brain. We
how that while the major rodent expression pattern is
onserved for AQP4, there are some differences be-
ween rodents and non-human primates for AQP1 and 9.
his knowledge is highly relevant for future development
nd testing of new drugs aimed to directly modify the
ermeability properties of AQPs to prevent edema for-
ation in brain diseases.
QP4 distribution
imilarly to previous description in rodent brains, AQP4
rotein was found in perivascular astrocytic endfeet, and in
ontrast to AQP1, mainly in grey matter, but also in the glia
imitans and pia mater. As previously described (Badaut et
s. Large arrow heads indicate the co-localization (yellow) in the glia limitans.
We also observe astrocytic prolongations that areGFAP positive, but AQP1
green and DAPI in blue. Double immunolabeling reveals AQP1 and GFAP
and a predominant AQP1 immunoreactive pia mater, containing vascular
open box in Fig. 5D, allows the identification of GFAP (green)-AQP1 (red)
fibers of oculomotor nerve axons (asterixes). (F) A closer look into the pia
fibers (double lined arrows) and cell bodies (arrows) interconnected by the
e is no detectable GFAP staining in the pia mater. Bar25 m in (B–D, F);
ader is referred to the Web version of this article.glia limitan
ngations.
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ndfeet. Generally, AQP4 labeling in primate brains is
imited to astrocytic perivascular endfeet. In accordance to
umerous previous reports in rodent brains (Badaut et
l., 2007; Tait et al., 2008), we suggest that this specific
QP4 localization, in close contact to the cerebral blood
essels, as well as at the interface of the cerebrospinal
uid (CSF)—brain barrier, shows an important role in
ig. 7. AQP9 immunoreactivity in a coronal Macaca fascicularis bra
nsula cortex (Ins), in the ventral (VTh), medial (MeTh) and reticular
n the glia limitans (pentagonal arrows), in the pia mater (single lin
ornu Ammonis fields CA1, CA2, CA3, in the dentate gyrus (DG) a
Fig. 4) where the staining is mostly found in white matter and arou
anglia system (except for the putamen and globus pallidus). The
gures. 3n, oculomotor nerve; 3V, third ventricle; bcc, body of corpu
LG, dorsal nucleus of lateral geniculate body; ec, external capsule
ossa; itha, interthalamic adhesion; lml, lateral medullary lamina; M
utamen; PPHG, posterior parahippocampal gyrus; Sub, subiculum
he precentral gyrus (PrG) as indicated in Fig. 7A, reveals express
strocytic cell bodies (Fig. 7B, double lined arrow) as well as in ova
) The hippocampus region reveals high AQP9-IR in the granule
odies (open arrow heads) and processes (arrows) in the granule c
odies in the granule cell layer of small cells (open arrow heads) an
ar1 cm in (A); Bar100 m in (E); bar25 m in (B–D, F).rain water homeostasis and in the formation and reab- rorption of brain edema. Our results highlight that brain
QP4 distribution is highly conserved between species
rom chicken (Goren et al., 2006; Saito et al., 2005) to
rimates (Fig. 2); suggesting that perivascular AQP4
lays a key role in brain water homeostasis in all spe-
ies. AQP4 was also observed in the granule cell layer in
he dentate gyrus of the hippocampus where we also
oted expression of AQP1 and AQP9. Their potential
n at 6 mm. (A) Staining is revealed in grey matter (asterix), in the
mic nuclei, in the tail (TCd) and body (BCd) of the caudate nucleus,
s), in the substantia nigra compacta (SNc) and reticulata (SNr), in
subiculum (Sub) of the hippocampus. Compared to AQP1 labeling
sal ganglia, AQP9 labeling is observed in the cortex and the basal
d squares are shown in higher magnification in the corresponding
m; BLV, body of lateral ventricle; ccr, cerebral crus; Cl, claustrum;
treme capsule; GP, globus pallidus; Ins, Insula; ipf, interpeduncular
dial thalamic nuclear group; pcfx, posterior column of fornix; Pu,
entral tegmental area. (B–D) Magnification of the cortical region of
QP9 in perivascular astrocytic endfeet (Fig. 7B, C, arrows) and in
cell bodies of 10 to 15 m of diameter (Fig. 7D, arrow heads). (E,
r. Higher magnification allows identification of immunolabeled cell
f the dentate gyrus. In Fig. 7F, higher magnification shows the cell
cells (arrow), suggesting the presence of two populations of cells.in sectio
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s previously proposed for rodent brains (Nielsen et al.,
993; Oshio et al., 2005), AQP1 may contribute to cere-
rospinal fluid formation in Macaca fascicularis brains.
hole brain analysis of AQP1 expression showed three
dditional locations in Macaca fascicularis: (1) in astro-
ytes, with a preference for white matter astrocytes (Fig.
A); (2) in Schwann cells surrounding the oculomotor (Fig.
D, E) and trigeminal (data not shown) cranial nerve fibers;
nd (3) in neurons on the surface of the pial blood vessels
Fig. 6B).
For the first time inMacaca fascicularis brain, we report
QP1 expression in astrocytic soma in white matter and
he glia limitans as well as in their prolongations and vas-
ular endfeet. In contrast to AQP4, only approximately one
ut of four GFAP-positive astrocytes were labeled by anti-
QP1. AQP1 was preferentially expressed in astrocytes of
he white matter, suggesting that AQP1 may be a marker
ig. 8. (A, B) AQP9 immunolabeling in the substantia nigra compac
euronal processes were also stained with AQP9 (B). (C–E) TH (red)
E) reveals an AQP9-staining of cell bodies (Fig. 8C, arrow) with the
xpression in catecholaminergic neurons. We note both cytoplasmic
xpressed in the membrane of catecholaminergic neurons (Fig. 8D,
eferences to color in this figure legend, the reader is referred to thef a sub-population of astrocytes. In grey matter, the most bbundant type of astrocyte is the protoplasmic astrocyte.
uman protoplasmic astrocytes have numerous pro-
esses and a 27-fold greater volume than protoplasmic
strocytes found in rodents (Oberheim et al., 2006). Fi-
rous astrocytes show less ramifications than protoplas-
ic astrocytes and have fewer GFAP-positive processes
hich, in contrast to protoplasmic processes, intermingle
nd do not respect a domain structure (Oberheim et al.,
006). In accordance with findings in human brain tissue
Satoh et al., 2007), our results in Macaca fascicularis
rain suggest that AQP1 is a marker of fibrous astrocytes
hich seem to exhibit highly branched processes (Fig.
C). AQP1 may play a complementary role to AQP4 in
strocytes in the regulation of brain water homeostasis in
rimates.
Recently, expression of AQP1 in reactive astrocytes
as shown in human brain pathologies, such as Alzhei-
er’s disease, multiple sclerosis, ischemic brain lesions,
ositive cell bodies (arrows) in (A) and (B) (at higher magnification).
9 (green)-double immunofluorescent staining of substantia nigra (Fig.
orphology as TH positive neurons (Fig. 8D, arrow), showing AQP9
mbrane expression of AQP9 (Fig. 8C, arrow), whereas TH is only
Bar50 m in (A); Bar 25 m in (B–E). For interpretation of the
ion of this article.ta with p
and AQP
same m
and merain edema and epilepsy (Badaut et al., 2003; Misawa et
a
s
(
l
w
S
w
m
i
f
d
a
m
b
i
i
l
m
h
t
S
n
w
(
p
h
n
A
g
S
e
i
e
w
c
r
t
S
b
i
k
s
p
k
t
d
g
a
i
p
t
s
2
c
c
a
b
c
A
A
m
l
e
s
n
i
i
m
c
c
m
a
p
p
t
i
c
c
i
p
m
t
r
m
i
r
w
p
c
g
p
p
p
i
a
w
b
A
s
s
2
p
o
S
A
c
p
(
e
I. I. Arciénega et al. / Neuroscience 167 (2010) 1103–11141112l., 2008; Satoh et al., 2007). Some studies have also
hown an intracellular location for AQP1 in astrocytes
Dohke and Turner, 2002; Marinelli et al., 1997). In patho-
ogical conditions, AQP1 is proposed to play a role in brain
ater movement (Badaut et al., 2003; Satoh et al., 2007;
uzuki et al., 2006). However, AQP1 as well as AQP4
ere recently shown to be involved in cell growth and
igration (Saadoun et al., 2005a,b) and therefore, AQP1
n collaboration with AQP4 may play a role in glial scar
ormation by facilitating cell migration in pathological con-
itions. In normal primate brains, the presence of AQP1 in
single population of astrocytes suggests that this subtype
ay be dedicated to the rapid mobilization of cells after
rain injury. This population of astrocytes with highly ram-
fied processes is a population which detects modifications
n the environment by rapid formation of filopodia. In patho-
ogical states, these AQP1 positive astrocytes could be
ore rapidly recruited to form reactive astrocytes. This
ypothesis is coherent with observations of AQP1 in reac-
ive astrocytes in several diseases (Badaut et al., 2003;
atoh et al., 2007; Suzuki et al., 2006).
Additional glial locations were also shown in peripheral
erves with GFAP-AQP1 co-expression in Schwann cells
hich envelop the oculomotor (Fig. 5D, E) and trigeminal
not shown) nerve fibers. The presence of AQP1 was
reviously reported in distant Schwann cells and also in
uman peripheral nerves (such as pancreatic and sciatic
erve bundles) (Gao et al., 2006; Nandasena et al., 2007).
QP4 expression was not observed in oculomotor or tri-
eminal nerve axons, suggesting that AQP1 is a marker of
chwann cells which myelinate nerve axons in the periph-
ral nervous system. As suggested above, AQP1 may be
nvolved in water homeostasis in myelinated axons during
lectrical activity. However, more functional experiments
ill be necessary to determine the exact function of this
hannel in peripheral nerves.
AQP1 was also reported in primary sensory neurons in
odents and proposed to play a role in nociception, such as
hermal and chemical pain reception (Oshio et al., 2006;
hields et al., 2007). In addition to these locations in rodent
rains, we report for the first time that AQP1 is expressed
n neuronal cell bodies and axons on pial vessels in mon-
eys (Figs. 5D, F and 6). Recent experiments in rodents
howed that AQP1 is expressed in sensory neurons ex-
ressing substance P (Shields et al., 2007). It is well
nown that the pial blood vessels are innervated by pep-
idergic (substance P) and nitrergic neurons coming from
ifferent ganglia, such as the trigeminal and sphenopalatin
anglia respectively (Iadecola et al., 1994; Yamamoto et
l., 1983). Taken together, we suggest that AQP1 protein
s found in peptidergic and nitrergic neurons running on
ial blood vessels. Recently, AQP1 was shown to facilitate
he diffusion of nitric oxide (NO) and to contribute to va-
orelaxation (Herrera and Garvin, 2007; Herrera et al.,
006), raising the hypothesis that neuronal AQP1 may
ontribute to NO diffusion from neurons to smooth muscle
ells of pial blood vessels.
In summary, the biggest differences between rodents
nd non-human primates were observed for AQP1 distri- cution with new cell locations such as astrocytes, Schwann
ells and pial blood vessel innervations.
QP9 distribution and its potential roles
QP9 is an aquaglyceroporin, which means it is also per-
eable to glycerol, urea and monocarboxylates, such as
actate. We have suggested a role for AQP9 in brain en-
rgy homeostasis (Badaut et al., 2007) and have de-
cribed its expression in astrocytes and catecholaminergic
eurons (Badaut and Regli, 2004). The level of expression
n the brain as well as in the liver is regulated by plasma
nsulin concentrations, arguing for a role of AQP9 in energy
etabolism (Badaut et al., 2008). However, immunocyto-
hemical analyses have provided divergent results con-
erning the expression of AQP9 in brain. Its presence in
ice brain was questioned (Rojek et al., 2007) but was
lso confirmed in rat and mouse tyrosine hydroxylase-
ositive neurons, in hilar and pyramidal cells of hippocam-
us as well as in numerous cell populations in the neocor-
ex (Mylonakou et al., 2009). Mylonakou et al. (2009) stud-
ed several antibodies used in the various studies and
oncluded that the inconsistency between the immnocyto-
hemical studies reflects differences between the specific-
ty of antibodies used. They conclude that the AQP9 rabbit
olyclonal antibody from Alpha Diagnostics produces the
ost reliable results (Mylonakou et al., 2009) and as with
heir studies, this study has been conducted with AQP9
abbit polyclonal antibody from Alpha Diagnostics.
We demonstrate the presence of AQP9 mRNA in pri-
ate slices adjacent to those used in immunohistochem-
stry. The results are in agreement with previous studies in
odent brains (Badaut et al., 2004; Mylonakou et al., 2009),
here we observe AQP9 protein in astrocyte cell bodies,
rocesses and endfeet in grey matter (Fig. 7C, D) and in
atecholaminergic neurons (Fig. 8). Here, we provide ar-
uments for the expression of AQP9 in the non-human
rimate brain. However, the exact role of this aquaglycero-
orin is still hypothetical and needs further investigation.
The presence of AQP9 was also observed in a second
opulation of neurons in monkey brains with an oval shape
n layer IV of the precentral gyrus (Fig. 7A) and the DG
rea of the hippocampus. This distribution is in accordance
ith the pattern of AQP9 mRNA distribution in mouse
rains (Mylonakou et al., 2009). The functional role of
QP9 in these cells needs to be studied further.
Interestingly, the pattern of AQP9, AQP4 and AQP1
taining in the DG is similar to the staining observed in the
ub-ventricular zone in rodent brains (Cavazzin et al.,
006). The latter location is known to be a niche for adult
rogenitor cells (Cavazzin et al., 2006) as well as the DG
f the hippocampus (Gage, 1998; Palmer et al., 1997;
ong et al., 2002). The presence of AQP9, AQP4 and
QP1 in these regions suggests expression in progenitor
ells. In agreement, previous studies have reported the
resence of AQP9 and AQP4 in murine neural stem cells
NSC) (Cavazzin et al., 2006; La Porta et al., 2006). High
xpression of these AQPs (AQP1, AQP4, AQP9) in neural
ell progenitor niches may be related to the high prolifer-
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ater and energy homeostasis.
CONCLUSION
n conclusion, the present study is the first to demonstrate
he presence of the three major AQPs in Macaca fascicu-
aris brains. AQP4 is the major aquaporin, expressed ex-
lusively in astrocytes with a preferential location in
erivascular astrocyte endfeet. We show an interesting
istribution of AQP1 in a sub-population of astrocytes. Its
ole in these cells is not yet determined and needs further
nvestigation. Our work suggests that results obtained in
revious studies in pathological rodent models such as
rain ischemia with AQPs cannot automatically be trans-
osed to human clinical studies. We suggest that AQP4 is
ot involved alone in brain water homeostasis, but that
QP1 may also be part of the regulation process. AQP9
RNA and proteins are present in primate brain, with
dditional locations in the cortex and hippocampus. Fur-
her investigation in brains with models of non-human pri-
ate pathologies will be extremely useful to determine
ossible roles of each AQP in edema and other pathophys-
ological mechanisms.
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